SYRS Projected Dividend Yield
Syros Pharmaceuticals Inc ( OTCBB : SYRS )Syros Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing new treatments for hematologic malignancies. It is advancing Tamibarotene, a selective RARa agonist, in Phase III and Phase II trials for higher-risk myelodysplastic syndrome (HR-MDS) and acute myeloid leukemia (AML), respectively. Other assets include SY-2101 and SY-5609, with the latter being a potent CDK7 inhibitor for which the company is seeking out-licensing opportunities. 21 YEAR PERFORMANCE RESULTS |
SYRS Dividend History Detail SYRS Dividend News SYRS Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |